KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Times Interest Earned (2017 - 2022)

Sarepta Therapeutics has reported Times Interest Earned over the past 6 years, most recently at -$15.97 for Q4 2022.

  • For Q4 2022, Times Interest Earned fell 68.52% year-over-year to -$15.97; the TTM value through Sep 2023 reached -$59.7, down 476.85%, while the annual FY2023 figure was -$12.17, 20.84% down from the prior year.
  • Times Interest Earned for Q4 2022 was -$15.97 at Sarepta Therapeutics, up from -$20.78 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$1.67 in Q3 2021 and troughed at -$444.11 in Q1 2019.
  • A 5-year average of -$34.41 and a median of -$10.34 in 2020 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: crashed 10929.44% in 2019 and later skyrocketed 98.05% in 2020.
  • Year by year, Times Interest Earned stood at -$19.23 in 2018, then crashed by 42.73% to -$27.44 in 2019, then soared by 75.83% to -$6.63 in 2020, then plummeted by 42.95% to -$9.48 in 2021, then plummeted by 68.52% to -$15.97 in 2022.
  • Business Quant data shows Times Interest Earned for SRPT at -$15.97 in Q4 2022, -$20.78 in Q3 2022, and -$12.45 in Q2 2022.